CINECA IRIS Institutional Research Information System

CITI, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.907
AS - Asia 3.464
EU - Europa 2.842
SA - Sud America 507
AF - Africa 165
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 4
Totale 12.899
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.739
IT - Italia 1.286
SG - Singapore 1.067
CN - Cina 949
HK - Hong Kong 547
BR - Brasile 411
VN - Vietnam 411
SE - Svezia 373
DE - Germania 282
BG - Bulgaria 165
FR - Francia 157
GB - Regno Unito 128
FI - Finlandia 102
CA - Canada 101
IN - India 83
AT - Austria 81
JP - Giappone 74
RU - Federazione Russa 72
KR - Corea 68
TR - Turchia 66
CI - Costa d'Avorio 56
PL - Polonia 48
NL - Olanda 40
MX - Messico 39
BD - Bangladesh 37
AR - Argentina 34
ZA - Sudafrica 32
IQ - Iraq 30
CH - Svizzera 21
SA - Arabia Saudita 20
BE - Belgio 16
EC - Ecuador 16
KE - Kenya 16
SN - Senegal 15
UZ - Uzbekistan 14
ID - Indonesia 13
UA - Ucraina 12
VE - Venezuela 12
CO - Colombia 11
ES - Italia 11
GR - Grecia 11
NG - Nigeria 10
PK - Pakistan 10
EU - Europa 9
TN - Tunisia 9
CZ - Repubblica Ceca 7
MA - Marocco 7
DZ - Algeria 6
EG - Egitto 6
HU - Ungheria 6
IL - Israele 6
JM - Giamaica 6
JO - Giordania 6
PS - Palestinian Territory 6
TW - Taiwan 6
BO - Bolivia 5
LT - Lituania 5
MY - Malesia 5
NI - Nicaragua 5
PE - Perù 5
PH - Filippine 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CL - Cile 4
NP - Nepal 4
RO - Romania 4
AU - Australia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GE - Georgia 3
HN - Honduras 3
IR - Iran 3
KZ - Kazakistan 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AL - Albania 2
BB - Barbados 2
ET - Etiopia 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
OM - Oman 2
QA - Qatar 2
SY - Repubblica araba siriana 2
AO - Angola 1
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
GD - Grenada 1
GY - Guiana 1
HR - Croazia 1
IE - Irlanda 1
KH - Cambogia 1
Totale 12.886
Salva come PNG Salva come JPEG
Città #
Ashburn 615
Singapore 584
Hong Kong 532
Fairfield 457
San Jose 418
Serra 384
Santa Clara 354
Woodbridge 352
Dallas 337
Chandler 310
Houston 258
Seattle 208
Ann Arbor 197
Beijing 197
Wilmington 167
Sofia 164
Shanghai 162
Cambridge 129
Milan 121
Boardman 120
Los Angeles 116
New York 113
Council Bluffs 112
Chicago 108
Hefei 99
Hanoi 89
Ho Chi Minh City 86
Munich 79
Princeton 79
Pisa 77
Vienna 73
Lawrence 66
Tokyo 63
Seoul 62
Florence 61
Lauterbourg 60
Ottawa 59
Frankfurt am Main 58
Abidjan 56
Medford 56
Rome 56
London 55
Helsinki 43
Dong Ket 42
Warsaw 42
Des Moines 38
São Paulo 37
Buffalo 35
Istanbul 30
Nanjing 30
Redondo Beach 28
Orem 25
Salt Lake City 25
Turku 24
Marseille 22
Johannesburg 21
Lucca 21
Dearborn 20
Da Nang 19
Nuremberg 18
San Diego 18
Boulder 17
Grafing 17
Livorno 17
Zurich 17
Elk Grove Village 16
Izmir 16
Lappeenranta 16
Dakar 15
Naples 15
Paris 15
Phoenix 15
Brussels 14
Quanzhou 14
Amsterdam 13
Atlanta 13
Bremen 13
Fuzhou 13
Mumbai 13
Redwood City 13
The Dalles 13
Baltimore 12
Guangzhou 12
Mexico City 12
Washington 12
Brooklyn 11
Düsseldorf 11
Nanchang 11
Napoli 11
Ogden 11
San Francisco 11
Tashkent 11
Tianjin 11
Toronto 11
Baghdad 10
Haiphong 10
Massa 10
Tampa 10
Belo Horizonte 9
Changsha 9
Totale 8.787
Salva come PNG Salva come JPEG
Nome #
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 297
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 296
The Citrus Flavonoid Naringenin Protects the Myocardium from Ageing-Dependent Dysfunction: Potential Role of SIRT1 256
New activators of SIRT1 enzyme for the treatment of cardiovascular and cardiometabolic pathologies 245
The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress 237
Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of brassicaceae? 232
Anti-Inflammatory Effect of the Natural H2S-Donor Erucin in Vascular Endothelium 225
Metformin conjugates and therapeutic use thereof 224
Memantine prodrug as a new agent for alzheimer’s disease 223
Nuovi attivatori dell’enzima SIRT1 per il trattamento delle patologie cardiovascolari e cardiometaboliche 221
First examples of H2S-releasing glycoconjugates: stereoselective synthesis and anticancer activities 221
1,2,4-Thiadiazolidin-3,5-diones as novel hydrogen sulfide donors 217
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 213
Association of KRAS mutations in cell-free circulating tumor DNA with occurrence of resistance to TKIs in NSCLC 209
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 203
Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA 203
Design and synthesis of H2S-donor hybrids: A new treatment for Alzheimer's disease? 198
D -Penicillamine modulates hydrogen sulfide (H2S) pathway through selective inhibition of cystathionine-γ-lyase 196
Pharmacological characterization of the vascular effects of aryl isothiocyanates: Is hydrogen sulfide the real player? 193
Impact of mucoadhesive polymeric nanoparticulate systems on oral bioavailability of a macromolecular model drug 188
Mitochondriotropic and Cardioprotective Effects of Triphenylphosphonium-Conjugated Derivatives of the Diterpenoid Isosteviol 179
DPYD and UGT1A1 genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancer 178
Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro 178
Anticancer properties of erucin, an H2S-releasing isothiocyanate, on human pancreatic adenocarcinoma cells (AsPC-1) 172
Association of Myo-Inositol and Microlipodispersed Magnesium in Androgen-Dependent Dermatological Diseases: A Retrospective Study 171
Anti-Inflammatory and Vasorelaxant Effects Induced by an Aqueous Aged Black Garlic Extract Supplemented with Vitamins D, C, and B12 on Cardiovascular System 169
Iminothioethers as a novel class of H2S-donor: gasotransmitter release and vascular effects 169
H2S donating corticosteroids: Design, synthesis and biological evaluation in a murine model of asthma 168
Erucin exhibits vasorelaxing effects and antihypertensive activity by H 2 S-releasing properties 165
Effect of glucoraphanin and sulforaphane against chemotherapy-induced neuropathic pain: Kv7 potassium channels modulation by H2S release in vivo 162
The Renal Outer Medullary Potassium channel (ROMK): an intriguing pharmacological target for an innovative class of diuretic drugs 153
Structure-activity relationships study of isothiocyanates for H2S releasing properties: 3-Pyridyl-isothiocyanate as a new promising cardioprotective agent 152
Sirtuin 1-Activating Compounds: Discovery of a Class of Thiazole-Based Derivatives 150
Ex vivo and in vivo study of sucrosomial® iron intestinal absorption and bioavailability 149
THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES: CHEMOTYPES OF SLOW H2S-RELEASING AGENTS 148
Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel? 147
Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA 146
The role of hydrogen sulfide and H2S-donors in myocardial protection against ischemia/reperfusion injury 146
Pathophysiological role of mitochondrial potassium channels and their modulation by drugs 143
A Novel H2S-releasing Amino-Bisphosphonate which combines bone anti-catabolic and anabolic functions 143
null 142
Anti-Proliferative Properties of the Novel Hybrid Drug Met-ITC, Composed of the Native Drug Metformin with the Addition of an Isothiocyanate H2S Donor Moiety, in Different Cancer Cell Lines 137
Anomalous Kv7 channel activity in human malignant hyperthermia syndrome unmasks a key role for H2S and persulfidation in skeletal muscle 133
New Synthetic Analogues of Natural Polyphenols as Sirtuin 1-Activating Compounds 133
KRAS mutations as potential mechanism of crizotinib acquired resistance: a study on circulating tumor DNA 132
Mercaptopyruvate acts as endogenous vasodilator independently of 3-mercaptopyruvate sulfurtransferase activity 129
Cardiovascular benefits of Eruca sativa mill. Defatted seed meal extract: Potential role of hydrogen sulfide 128
Sirtuin 1-activating derivatives belonging to the anilinopyridine class displaying in vivo cardioprotective activities 127
Nutraceutical Features of the Phycobiliprotein C-Phycocyanin: Evidence from Arthrospira platensis (Spirulina) 126
Role of hydrogen sulfide in endothelial dysfunction: Pathophysiology and therapeutic approaches 124
Iminothioethers As A Novel Class Of H2s-Donor: Gasotransmitter Release And Vascular Effects 123
Vascular effects of H2S-donors: Fluorimetric detection of H2S generation and ion channel activation in human aortic smooth muscle cells 123
Anti-metastatic Properties of Naproxen-HBTA in a Murine Model of Cutaneous Melanoma 122
Advances in Technologies for Highly Active Omega-3 Fatty Acids from Krill Oil: Clinical Applications 121
Searching for novel hydrogen sulfide donors: The vascular effects of two thiourea derivatives 118
KRAS has a role in acquired resistance to EGFR-TKIs in NSCLC: an analysis on circulating tumor DNA 117
Organic Isothiocyanates as Hydrogen Sulfide Donors 117
Role of hydrogen sulfide in cardiovascular ageing 116
Development of an adipocyte differentiation protocol using 3T3-L1 cells for the investigation of the browning process: identification of the PPAR-γ agonist rosiglitazone as a browning reference drug 115
Plants and Mushrooms as Possible New Sources of H2S Releasing Sulfur Compounds 113
null 113
In Vitro Models of Diabetes: Focus on Diabetic Retinopathy 112
Design, Synthesis and Evaluation of Novel Molecular Hybrids between Antiglaucoma Drugs and H2S Donors 111
New Visions on Natural Products and Cancer Therapy: Autophagy and Related Regulatory Pathways 104
Pharmacological evaluation of aryl-isothiocyanates as original H2S-donor derivatives: H2S-release and vascular effects 100
null 100
null 98
Natural organo-sulfur compounds inhibit RBL-2H3 mast cell degranulation 97
The novel H2S donor 4-carboxy-phenyl isothiocyanate inhibits mast cell degranulation and renin release by decreasing intracellular calcium 97
Hybrids between H2S-donors and betamethasone 17-valerate or triamcinolone acetonide inhibit mast cell degranulation and promote hyperpolarization of bronchial smooth muscle cells 97
Tumor suppressor role of hsa-mir-193a-3p and-5p in cutaneous melanoma 96
The h2 s-donor erucin exhibits protective effects against vascular inflammation in human endothelial and smooth muscle cells 94
Should CYP2D6 be genotyped when treating with tamoxifen? [Letter in reply] 93
5α-dihydrotestosterone abrogates sex bias in asthma like features in the mouse 93
null 92
Functional recovery of islet β cells in human type 2 diabetes: Transcriptome signatures unveil therapeutic approaches 91
DPYD c.1905+1G>A and c.2846 A>T and UGT1A1*28 allelic variants as predictors of toxicity: Pharmacogenetic translational analysis from the phase III TRIBE study in metastatic colorectal cancer. 91
Anti-inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H2S donors in COVID-19 therapy 91
Influence of Polyphenols on Adipose Tissue: Sirtuins as Pivotal Players in the Browning Process 90
Development of In Vitro Corneal Models: Opportunity for Pharmacological Testing 90
Early ctDNA dynamics as a surrogate for progression-free survival in advanced breast cancer in the BEECH trial 89
Using hydrogen sulfide to design and develop drugs 87
Isothiocyanate-Corticosteroid Conjugates against asthma: Unity makes strength 84
Should CYP2D6 be genotyped when treating with tamoxifen? 76
Hydrogen sulfide: The hidden player of isothiocyanates pharmacology 75
Recent Advancements in Production and Extraction Methods of Phycobiliprotein C-phycocyanin by Arthrospira (Spirulina) platensis: A Mini Review 73
Pharmacological evaluation of innovative eye drop formulations containing TS-polysaccaride, hyaluronic acid and glycyrrhizin for irritative ocular diseases using in vitro reconstituted human corneal epithelium model 68
Regulation of blood pressure by natural sulfur compounds: Focus on their mechanisms of action 66
Potential Effects of Natural H2 S-Donors in Hypertension Management 64
null 60
Glucoraphanin Increases Intracellular Hydrogen Sulfide (H2S) Levels and Stimulates Osteogenic Differentiation in Human Mesenchymal Stromal Cell 59
Recent efforts in drug discovery on vascular inflammation and consequent atherosclerosis 59
Synthesis and biological evaluation of N–O heterobicyclic ring systems derived from 1,2-dihydropyridines as novel TRPA1 activators: implication in GLP-1 release and neuroprotection 57
Real-World Pilot Evaluation of a Novel Bioavailable Berberine Formulation (ToBeRock®) in Subjects with Impaired Fasting Glucose Through Pharmacy-Based Retrospective Study 48
null 48
Glucotropaeolin-enriched Lepidium sativum L. extract as a novel phytotherapy for tendinopathy: mechanistic insights into pain modulation 40
Design, synthesis and biological evaluation of new H2S-releasing rivastigmine derivatives as neuroprotective molecules 38
Naturally Occurring H2S-Donors in Vascular Diseases 25
Semi-Synthetic H2S Releasing Compounds with Antioxidant and Vasorelaxant Properties 24
Biocompatible molecularly imprinted polynorepinephrine nanoparticles: rational design and one-step reversible immobilization for enhanced protein recognition by surface plasmon resonance 20
Totale 13.291
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.047
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.047
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021200 0 0 0 0 0 0 0 0 0 0 75 125
2021/2022771 23 24 17 22 126 135 25 34 47 39 67 212
2022/20231.272 149 179 98 80 125 162 12 80 245 15 74 53
2023/2024762 55 79 87 37 99 131 55 28 7 22 46 116
2024/20253.038 46 94 32 149 241 326 231 140 264 445 475 595
2025/20263.901 207 474 409 383 365 324 688 199 330 433 89 0
Totale 13.305